Expression Profiling of Breast Cancer Cells by Differential Peptide Display

Expression profiling of RNAs or proteins has become a promising means to investigate the heterogeneity of histopathologically defined classes of cancer. Peptides, representing degradation as well as processing products of proteins offer an even closer insight into cell physiology. Peptides are related to the turnover of cellular proteins and are capable to reflect disease-related changes in homoeostasis of the human body. Furthermore, peptides derived from tumor cells are potentially useful markers in the early detection of cancer.In this study, we introduced a method called differential peptide display (DPD) for separating, detecting, and identifying native peptides derived from whole cell extracts. This method is a highly standardized procedure, combining the power of reversed-phase chromatography with mass spectrometry. This technology is suitable to analyze cell lines, various tissue types and human body fluids. Peptide-based profiling of normal human mammary epithelial cells (HMEC) and the breast cancer cell line MCF-7 revealed complex peptide patterns comprising of up to 2300 peptides. Most of these peptides were common to both cell lines whereas about 8% differed in their abundance. Several of the differentially expressed peptides were identified as fragments of known proteins such as intermediate filament proteins, thymosins or Cathepsin D. Comparing cell lines with native tumors, overlapping peptide patterns were found between HMEC and a phylloides tumor (CP) on the one hand and MCF-7 cells and tissue from a invasive ductal carcinoma (DC) on the other hand.

[1]  D. Germain,et al.  Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer , 1999, Oncogene.

[2]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[3]  K. Yamaguchi,et al.  Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma. , 1994, Cancer research.

[4]  M. Schrader,et al.  Peptidomics technologies for human body fluids. , 2001, Trends in biotechnology.

[5]  R H Hruban,et al.  Gene expression profiles in normal and cancer cells. , 1997, Science.

[6]  H. Nakanishi,et al.  New Functional Aspects of Cathepsin D and Cathepsin E , 2000, Molecules and cells.

[7]  S. Carr,et al.  Phosphopeptide analysis by matrix-assisted laser desorption time-of-flight mass spectrometry. , 1996, Analytical chemistry.

[8]  S. Weinberger,et al.  Recent advancements in surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry , 2000, Electrophoresis.

[9]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[10]  V. Kosma,et al.  Prognostic value of cathepsin-D expression in female breast cancer. , 1995, Anticancer research.

[11]  E. Dougherty,et al.  Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.

[12]  Ash A. Alizadeh,et al.  Towards a novel classification of human malignancies based on gene expression patterns , 2001, The Journal of pathology.

[13]  N. Gebbia,et al.  Cathepsin D in the malignant progression of neoplastic diseases (review). , 1992, Anticancer research.

[14]  R. Moll,et al.  Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas , 1998, Virchows Archiv.

[15]  Hans-Georg Rammensee,et al.  Perfect use of imperfection , 2000, Nature.

[16]  M. F. Bean,et al.  Integration of mass spectrometry in analytical biotechnology. , 1991, Analytical chemistry.

[17]  David E. Misek,et al.  Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  A. Vlahou,et al.  Proteomic approaches to biomarker discovery in prostate and bladder cancers , 2001, Proteomics.

[19]  S. Ethier,et al.  Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis. , 2001, Analytical chemistry.

[20]  D. Chalbos,et al.  Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  P. Yaswen,et al.  Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  H. Rochefort,et al.  Cathepsin D in cancer metastasis: A protease and a ligand , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[23]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[24]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[25]  M. Schrader,et al.  Detection of low-molecular-mass plasma peptides in the cavernous and systemic blood of healthy men during penile flaccidity and rigidity--an experimental approach using the novel differential peptide display technology. , 2002, Urology.

[26]  M. Schrader,et al.  Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. , 2012, Combinatorial chemistry & high throughput screening.

[27]  J. Yates.  Mass spectrometry and the age of the proteome. , 1998, Journal of mass spectrometry : JMS.

[28]  S. Bolkent,et al.  Detection of c-erbB-2 mRNAs Using Dig-Labelled Oligonucleotide Probe with in situ Hybridisation in Human Breast Carcinoma: Comparison with Immunohistochemical Results , 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[29]  G. Wright,et al.  Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. , 2001, The American journal of pathology.

[30]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[31]  H. Rochefort,et al.  Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[32]  R. Weigel,et al.  hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. , 1998, Biochemical and biophysical research communications.

[33]  H. Rochefort,et al.  Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. , 1986, Endocrinology.